Free Trial

Kazia Therapeutics (KZIA) SEC Filings & 10K Form

Kazia Therapeutics logo
$3.58 +0.09 (+2.58%)
Closing price 05/23/2025 03:59 PM Eastern
Extended Trading
$3.45 -0.13 (-3.63%)
As of 05/23/2025 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Kazia Therapeutics SEC Filings

DateFilerForm TypeView
05/15/2025
7:15 AM
Kazia Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/15/2025
7:18 AM
Kazia Therapeutics (Filer)
Form 424B3
05/15/2025
7:21 AM
Kazia Therapeutics (Filer)
Form 424B3
05/15/2025
7:24 AM
Kazia Therapeutics (Filer)
Form 424B3
04/15/2025
7:35 AM
Kazia Therapeutics (Filer)
Form 424B3
04/15/2025
7:26 AM
Kazia Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/15/2025
7:29 AM
Kazia Therapeutics (Filer)
Form 424B3
04/15/2025
7:32 AM
Kazia Therapeutics (Filer)
Form 424B3
03/31/2025
7:43 AM
Kazia Therapeutics (Filer)
Form 424B3
03/31/2025
7:40 AM
Kazia Therapeutics (Filer)
Form 424B3
03/31/2025
7:41 AM
Kazia Therapeutics (Filer)
Form 424B3
03/31/2025
7:39 AM
Kazia Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/19/2025
4:25 PM
Alumni Capital LP (Filed by)
Kazia Therapeutics (Subject)
Form SCHEDULE 13G/A
03/13/2025
6:00 AM
Kazia Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/21/2025
5:33 AM
Kazia Therapeutics (Filer)
Form 424B3
02/20/2025
3:53 PM
Kazia Therapeutics (Filer)
Form 424B3
02/20/2025
3:55 PM
Kazia Therapeutics (Filer)
Form 424B3
02/05/2025
11:15 PM
Kazia Therapeutics (Filer)
Form EFFECT
02/05/2025
3:39 PM
Kazia Therapeutics (Filer)
Form 424B3
02/03/2025
7:36 AM
Kazia Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/30/2025
3:31 PM
Kazia Therapeutics (Filer)
Form F-1
Registration statement for securities of certain foreign private issuers  
01/30/2025
6:57 AM
Kazia Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/30/2025
7:02 AM
Kazia Therapeutics (Filer)
Form 424B3
01/30/2025
7:05 AM
Kazia Therapeutics (Filer)
Form 424B3
01/16/2025
9:40 AM
Alumni Capital LP (Filed by)
Kazia Therapeutics (Subject)
Form SCHEDULE 13G
01/13/2025
7:00 AM
Kazia Therapeutics (Filer)
Form 424B5
01/13/2025
7:03 AM
Kazia Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/13/2025
7:05 AM
Kazia Therapeutics (Filer)
Form 424B3
01/13/2025
7:07 AM
Kazia Therapeutics (Filer)
Form 424B3
01/10/2025
7:00 AM
Kazia Therapeutics (Filer)
Form 424B5
12/31/2024
7:46 AM
Kazia Therapeutics (Filer)
Form 424B3
12/31/2024
7:49 AM
Kazia Therapeutics (Filer)
Form 424B3
12/31/2024
7:43 AM
Kazia Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/11/2024
8:01 AM
Kazia Therapeutics (Filer)
Form 424B3
12/11/2024
8:04 AM
Kazia Therapeutics (Filer)
Form 424B3
12/11/2024
7:58 AM
Kazia Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/03/2024
3:33 PM
Kazia Therapeutics (Filer)
Form 424B3
12/03/2024
3:38 PM
Kazia Therapeutics (Filer)
Form 424B3
12/02/2024
11:15 PM
Kazia Therapeutics (Filer)
Form EFFECT
12/02/2024
11:15 PM
Kazia Therapeutics (Filer)
Form EFFECT
11/27/2024
3:30 PM
Kazia Therapeutics (Filer)
Form POS AM
White House to reset Social Security? (Ad)

Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington.

And it could have a major impact on how you collect Social Security - Click here to understand what'
11/27/2024
3:30 PM
Kazia Therapeutics (Filer)
Form POS AM
11/06/2024
6:53 PM
Kazia Therapeutics (Subject)
PLATINUM INVESTMENT MANAGEMENT LTD (Filed by)
Form SC 13G
11/01/2024
3:05 PM
Kazia Therapeutics (Filer)
Form NT 20-F
10/24/2024
7:28 AM
Kazia Therapeutics (Filer)
Form 424B3
10/24/2024
7:33 AM
Kazia Therapeutics (Filer)
Form 424B3
10/24/2024
7:38 AM
Kazia Therapeutics (Filer)
Form 424B3
10/24/2024
7:22 AM
Kazia Therapeutics (Filer)
Form 6-K/A
10/15/2024
6:01 AM
Kazia Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/15/2024
6:03 AM
Kazia Therapeutics (Filer)
Form 424B3
10/15/2024
6:04 AM
Kazia Therapeutics (Filer)
Form 424B3
10/15/2024
6:06 AM
Kazia Therapeutics (Filer)
Form 424B3
10/02/2024
3:52 PM
Kazia Therapeutics (Filer)
Form 424B3
10/02/2024
3:55 PM
Kazia Therapeutics (Filer)
Form 424B3
10/02/2024
3:57 PM
Kazia Therapeutics (Filer)
Form 424B3
09/23/2024
8:27 AM
Kazia Therapeutics (Filer)
Form 424B3
09/23/2024
8:23 AM
Kazia Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/23/2024
8:25 AM
Kazia Therapeutics (Filer)
Form 424B3
09/23/2024
8:26 AM
Kazia Therapeutics (Filer)
Form 424B3
09/13/2024
8:06 AM
Kazia Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/13/2024
8:10 AM
Kazia Therapeutics (Filer)
Form 424B3
09/13/2024
8:12 AM
Kazia Therapeutics (Filer)
Form 424B3
09/13/2024
8:14 AM
Kazia Therapeutics (Filer)
Form 424B3
09/12/2024
11:15 PM
Kazia Therapeutics (Filer)
Form EFFECT
09/04/2024
7:56 PM
Kazia Therapeutics (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
08/12/2024
6:28 PM
Alumni Capital LP (Filed by)
Kazia Therapeutics (Subject)
Form SC 13G/A
07/10/2024
8:26 AM
Kazia Therapeutics (Filer)
Form 424B3
07/10/2024
8:28 AM
Kazia Therapeutics (Filer)
Form 424B3
07/10/2024
8:28 AM
Kazia Therapeutics (Filer)
Form 424B3
07/10/2024
8:19 AM
Kazia Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/02/2024
4:29 PM
Alumni Capital LP (Filed by)
Kazia Therapeutics (Subject)
Form SC 13G
06/28/2024
3:27 PM
Kazia Therapeutics (Filer)
Form 424B3
06/24/2024
7:14 PM
Kazia Therapeutics (Filer)
Form F-1
Registration statement for securities of certain foreign private issuers  
06/04/2024
11:15 PM
Kazia Therapeutics (Filer)
Form EFFECT
05/29/2024
7:55 AM
Kazia Therapeutics (Filer)
Form F-1
Registration statement for securities of certain foreign private issuers  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:KZIA) was last updated on 5/25/2025 by MarketBeat.com Staff
From Our Partners